Precision Biosciences Inc (DTIL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 638 | 576 | 49,898 | 17,584 | 7,038 |
| Gross Profit | 638 | 576 | 49,898 | 17,584 | 7,038 |
| Operating Expenses | 25,484 | 21,851 | 25,752 | 21,771 | 21,928 |
| Operating Income | -24,846 | -21,275 | 24,146 | -4,187 | -14,890 |
| Interest Expense | 392 | 256 | 560 | 574 | 579 |
| Other Income | 7,493 | 5,106 | 9,163 | 13,349 | 2,035 |
| Pre-tax Income | -17,745 | -16,425 | 32,749 | 8,588 | -13,434 |
| Net Income Continuous | -17,745 | -16,425 | 32,749 | 8,588 | -13,434 |
| Net Income Discontinuous | N/A | N/A | N/A | N/A | -2,855 |
| Net Income | $-17,745 | $-16,425 | $32,749 | $8,588 | $-16,289 |
| EPS Basic Total Ops | -3.10 | -2.25 | 4.70 | 1.70 | -3.98 |
| EPS Basic Continuous Ops | -3.09 | -2.25 | 4.70 | 1.70 | -3.36 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | N/A | -0.62 |
| EPS Diluted Total Ops | -3.08 | -2.25 | 4.67 | 1.70 | -3.98 |
| EPS Diluted Continuous Ops | -3.07 | -2.25 | 4.67 | 1.70 | -3.36 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | N/A | -0.62 |
| EPS Diluted Before Non-Recurring Items | -3.20 | -2.83 | 3.46 | N/A | N/A |
| EBITDA(a) | $-24,278 | $-20,490 | $25,362 | $-2,874 | $-13,536 |